Slides on Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

Learn data and recommendations for initiating ART in a patient with transmitted antiretroviral drug resistance.
John D. Baxter, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 407 KB
Released: January 24, 2022

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

This downloadable patient education PDF reviews information on weight gain for people living with HIV initiating antiretroviral therapy

Michelle S. Cespedes, MD, MS Released: April 26, 2022

Slides from Dr Jason Schafer and Clinical Care Options (CCO): Antiretroviral stewardship can address key considerations for ART in the inpatient setting.

person default Jason Schafer, PharmD, MPH Released: February 14, 2022

Dr Jason Schafer and Clinical Care Options (CCO): Antiretroviral stewardship can address key considerations for ART in the inpatient setting.

person default Jason Schafer, PharmD, MPH Released: February 7, 2022

Clinical Care Options (CCO) expert insight by Dr Gail Matthews on what to consider when switching suppressed patients with HIV/HBV from oral to long-acting ART regimen

Prof Gail Matthews, MD, PhD Released: January 25, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings